首页 > 最新文献

Research and Reports in Urology最新文献

英文 中文
Unilateral Testicular Infarction a Very Rare Complication of Genital Tuberculosis: A Case Report and Literature Review. 单侧睾丸梗死是生殖器结核的一种罕见并发症:病例报告和文献复习。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-10-31 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S434046
Feysel Hassen Issack, Nahom Tadesse Bogale, Samater Mohammed Hassen, Abdulhafiz Idris Ibrahim, Abdurehman Mohamed Abdi, Tariku Mulatu Bore, Isak Omer Answar

Background: Genitourinary tuberculosis is the second most common form of extrapulmonary tuberculosis in developing countries. Isolated genital TB is rare, but testicular infarction is an unusual complication of delayed management, in which surgical intervention is warranted.

Case presentation: A 29-year-old male non-smoker presents with painful left scrotal pain of 21 days. Initially managed with intravenous antibiotics, the disease progressed and resulted in testicular infarction. Left orchiectomy was performed, and the specimen was sent for histopathological examination, which revealed features consistent with a testicular tuberculous abscess.

Conclusion: Tuberculous epididymo-orchitis (TBEO) with testicular infarction was unusual. It is prudent to consider this in patients presenting with long-standing urinary symptoms, particularly in those unresponsive to the initial antibiotic therapy. It requires a high index of suspicion, especially in TB endemic areas.

背景:生殖道结核是发展中国家第二常见的肺外结核。孤立性生殖器结核是罕见的,但睾丸梗死是延迟治疗的一种不寻常并发症,需要手术干预。病例介绍:一名29岁男性,不吸烟,左阴囊疼痛21天。最初使用静脉注射抗生素治疗,病情进展并导致睾丸梗死。进行了左侧睾丸切除术,并将标本送去进行组织病理学检查,结果显示其特征与睾丸结核性脓肿一致。结论:结核性附睾睾丸炎(TBEO)合并睾丸梗死是不常见的。谨慎的做法是,在出现长期泌尿系统症状的患者中考虑这一点,尤其是那些对最初的抗生素治疗没有反应的患者。它需要很高的怀疑指数,尤其是在结核病流行地区。
{"title":"Unilateral Testicular Infarction a Very Rare Complication of Genital Tuberculosis: A Case Report and Literature Review.","authors":"Feysel Hassen Issack,&nbsp;Nahom Tadesse Bogale,&nbsp;Samater Mohammed Hassen,&nbsp;Abdulhafiz Idris Ibrahim,&nbsp;Abdurehman Mohamed Abdi,&nbsp;Tariku Mulatu Bore,&nbsp;Isak Omer Answar","doi":"10.2147/RRU.S434046","DOIUrl":"10.2147/RRU.S434046","url":null,"abstract":"<p><strong>Background: </strong>Genitourinary tuberculosis is the second most common form of extrapulmonary tuberculosis in developing countries. Isolated genital TB is rare, but testicular infarction is an unusual complication of delayed management, in which surgical intervention is warranted.</p><p><strong>Case presentation: </strong>A 29-year-old male non-smoker presents with painful left scrotal pain of 21 days. Initially managed with intravenous antibiotics, the disease progressed and resulted in testicular infarction. Left orchiectomy was performed, and the specimen was sent for histopathological examination, which revealed features consistent with a testicular tuberculous abscess.</p><p><strong>Conclusion: </strong>Tuberculous epididymo-orchitis (TBEO) with testicular infarction was unusual. It is prudent to consider this in patients presenting with long-standing urinary symptoms, particularly in those unresponsive to the initial antibiotic therapy. It requires a high index of suspicion, especially in TB endemic areas.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"479-484"},"PeriodicalIF":1.6,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71426419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robot-assisted Surgery in the Field of Urology: The Most Pioneering Approaches 2015-2023. 泌尿外科领域的机器人辅助手术:最具开拓性的方法2015-2023。
IF 2 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-10-09 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S386025
Antonio Franco, Francesco Ditonno, Celeste Manfredi, Andrew D Johnson, Avinash Mamgain, Oren Feldman-Schultz, Carol L Feng, Antony A Pellegrino, Maria Carmen Mir, Francesco Porpiglia, Simone Crivellaro, Cosimo De Nunzio, Alexander K Chow, Riccardo Autorino

Robot-assisted surgery has emerged as a transformative technology, revolutionizing surgical approaches and techniques that decades ago could barely be imagined. The field of urology has taken charge in pioneering a new era of minimally invasive surgery with the ascent of robotic systems which offer enhanced visualization, precision, dexterity, and enabling surgeons to perform intricate maneuvers with improved accuracy. This has led to improved surgical outcomes, including reduced blood loss, lower complication rates, and faster patient recovery. The aim of our review is to present an evidence-based critical analysis on the most pioneering robotic urologic approaches described over the last eight years (2015-2023).

机器人辅助手术已经成为一项变革性技术,革命性地改变了几十年前难以想象的手术方法和技术。随着机器人系统的兴起,泌尿外科领域开创了微创手术的新时代,机器人系统提供了增强的可视化、精度和灵活性,并使外科医生能够以更高的精度进行复杂的操作。这导致了手术结果的改善,包括减少失血、降低并发症发生率和加快患者康复。我们综述的目的是对过去八年(2015-2023年)中描述的最具开创性的机器人泌尿外科方法进行循证批判性分析。
{"title":"Robot-assisted Surgery in the Field of Urology: The Most Pioneering Approaches 2015-2023.","authors":"Antonio Franco, Francesco Ditonno, Celeste Manfredi, Andrew D Johnson, Avinash Mamgain, Oren Feldman-Schultz, Carol L Feng, Antony A Pellegrino, Maria Carmen Mir, Francesco Porpiglia, Simone Crivellaro, Cosimo De Nunzio, Alexander K Chow, Riccardo Autorino","doi":"10.2147/RRU.S386025","DOIUrl":"10.2147/RRU.S386025","url":null,"abstract":"<p><p>Robot-assisted surgery has emerged as a transformative technology, revolutionizing surgical approaches and techniques that decades ago could barely be imagined. The field of urology has taken charge in pioneering a new era of minimally invasive surgery with the ascent of robotic systems which offer enhanced visualization, precision, dexterity, and enabling surgeons to perform intricate maneuvers with improved accuracy. This has led to improved surgical outcomes, including reduced blood loss, lower complication rates, and faster patient recovery. The aim of our review is to present an evidence-based critical analysis on the most pioneering robotic urologic approaches described over the last eight years (2015-2023).</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"453-470"},"PeriodicalIF":2.0,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/b4/rru-15-453.PMC10575039.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41238110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progressing Towards Same-Day Discharges After Robotic-Assisted Radical Prostatectomy; Safe and Cost Effective to Discharge Without Routine Blood Tests. 机器人辅助前列腺癌根治术后当天出院的进展;无需常规血液检查即可安全且经济高效地出院。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-10-09 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S429819
Bodie Chislett, Ghadir Omran, Michael Harvey, Damien Bolton, Nathan Lawrentschuk
<p><strong>Introduction: </strong>Changing population demographics and the recent SARS-CoV-2 pandemic have forever changed healthcare, with increasing demands on straining systems. The economic cost is yet to be fully realised, with growing concerns around the current system's ability to accommodate the ageing comorbid population. Consequently, a paradigm shift has taken place in healthcare systems, prioritizing cost accountability. In the absence of established guidelines or robust literature, the use of laboratory tests postoperatively is often guided solely by clinician preference. This study presents a retrospective analysis that investigates the utility and cost implications of routine postoperative investigation following robotic-assisted radical prostatectomies. The findings aim to emphasise the importance of evidence-based practices and cost-effective approaches in postoperative care.</p><p><strong>Materials/methods: </strong>A retrospective analysis was performed on all robotic-assisted radical prostatectomies (RARP) identified from a single institution between 29th June 2017 to 28th June 2019. This interval was chosen in an attempt to avoid bias or confounding variables associated with the SRS-CoV-2 pandemic. A single clinician conducted a comprehensive medical record review using unit record numbers corresponding to identified procedural codes. Demographics and variables were recorded, including postoperative test results, hospital length of stay and 30-day readmission rates. Patients were assigned to either 'Routine Postoperative tests' (RPOT) or 'No Routine Postoperative tests' (No RPOT) and a comparative analysis was performed. Using the Australian National Pharmaceutical Benefits Scheme (PBS) pricing guide, total expenditure was calculated.</p><p><strong>Results: </strong>A total of 319 patients were included in the study with an average of 2.5 tests per patient within the first 24 hours. Routine postoperative tests had no bearing on outcomes, with comparable readmission rates between cohorts, and a significantly shorter length of stay in the "No routine postoperative tests" group when compared to the "Routine Postoperative Tests". A total of 1028 tests were performed within the first 48 hours following surgery with expenditure on routine testing totalling $20,516 based on the Australian PBS pricing schedule. Abnormal results were returned on 96% of patients. In the RPOT group, 18 out of the 20 common interventions occurred from 302 RARP. Among the patients in the RPOT group, eight individuals underwent blood transfusions. However, none of these patients met the hospital-specific criteria for transfusion, which require a hemoglobin level below 70 or symptomatic presentation with a hemoglobin level below 80.</p><p><strong>Conclusion: </strong>The data suggests routine postoperative laboratory has no bearing on re-admission rates, with patients experiencing significantly shorter hospital stays. Furthermore, our results indicate ineff
引言:不断变化的人口结构和最近的严重急性呼吸系统综合征冠状病毒2型疫情永远改变了医疗保健,对紧张系统的需求越来越大。经济成本尚未完全实现,人们越来越担心当前系统适应老龄化共病人群的能力。因此,医疗保健系统发生了范式转变,优先考虑成本问责制。在缺乏既定指南或可靠文献的情况下,术后实验室测试的使用通常仅由临床医生的偏好指导。本研究提供了一项回顾性分析,调查机器人辅助前列腺根治术后常规术后调查的效用和成本影响。研究结果旨在强调循证实践和成本效益高的术后护理方法的重要性。材料/方法:对2017年6月29日至2019年6月28日期间从一家机构确定的所有机器人辅助前列腺根治术(RARP)进行回顾性分析。选择这一区间是为了避免与SRS-CoV-2大流行相关的偏见或混淆变量。一名临床医生使用与识别的程序代码相对应的单位记录编号进行了全面的医疗记录审查。记录人口统计学和变量,包括术后检查结果、住院时间和30天再次入院率。将患者分为“术后常规检查”(RPOT)或“无术后常规测试”(无RPOT),并进行比较分析。使用澳大利亚国家药品福利计划(PBS)定价指南,计算总支出。结果:共有319名患者被纳入研究,在前24小时内平均每位患者进行2.5次检测。常规术后检查与结果无关,队列之间的再入院率相当,与“常规术后测试”相比,“无常规术后检测”组的住院时间明显更短。在手术后的前48小时内,共进行了1028次检测,根据澳大利亚PBS定价表,常规检测支出总计20516美元。96%的患者出现异常结果。在RPOT组中,20种常见干预措施中有18种发生在302例RARP中。在RPOT组的患者中,有8人接受了输血。然而,这些患者都不符合医院特定的输血标准,即血红蛋白水平低于70或血红蛋白水平低于80的症状表现。结论:数据表明,常规术后实验室检查与再次入院率无关,患者住院时间明显缩短。此外,我们的研究结果表明,常规术后实验室的使用效率低下,临床干预措施很少,异常结果频繁,累积费用巨大。
{"title":"Progressing Towards Same-Day Discharges After Robotic-Assisted Radical Prostatectomy; Safe and Cost Effective to Discharge Without Routine Blood Tests.","authors":"Bodie Chislett,&nbsp;Ghadir Omran,&nbsp;Michael Harvey,&nbsp;Damien Bolton,&nbsp;Nathan Lawrentschuk","doi":"10.2147/RRU.S429819","DOIUrl":"10.2147/RRU.S429819","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Changing population demographics and the recent SARS-CoV-2 pandemic have forever changed healthcare, with increasing demands on straining systems. The economic cost is yet to be fully realised, with growing concerns around the current system's ability to accommodate the ageing comorbid population. Consequently, a paradigm shift has taken place in healthcare systems, prioritizing cost accountability. In the absence of established guidelines or robust literature, the use of laboratory tests postoperatively is often guided solely by clinician preference. This study presents a retrospective analysis that investigates the utility and cost implications of routine postoperative investigation following robotic-assisted radical prostatectomies. The findings aim to emphasise the importance of evidence-based practices and cost-effective approaches in postoperative care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials/methods: &lt;/strong&gt;A retrospective analysis was performed on all robotic-assisted radical prostatectomies (RARP) identified from a single institution between 29th June 2017 to 28th June 2019. This interval was chosen in an attempt to avoid bias or confounding variables associated with the SRS-CoV-2 pandemic. A single clinician conducted a comprehensive medical record review using unit record numbers corresponding to identified procedural codes. Demographics and variables were recorded, including postoperative test results, hospital length of stay and 30-day readmission rates. Patients were assigned to either 'Routine Postoperative tests' (RPOT) or 'No Routine Postoperative tests' (No RPOT) and a comparative analysis was performed. Using the Australian National Pharmaceutical Benefits Scheme (PBS) pricing guide, total expenditure was calculated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 319 patients were included in the study with an average of 2.5 tests per patient within the first 24 hours. Routine postoperative tests had no bearing on outcomes, with comparable readmission rates between cohorts, and a significantly shorter length of stay in the \"No routine postoperative tests\" group when compared to the \"Routine Postoperative Tests\". A total of 1028 tests were performed within the first 48 hours following surgery with expenditure on routine testing totalling $20,516 based on the Australian PBS pricing schedule. Abnormal results were returned on 96% of patients. In the RPOT group, 18 out of the 20 common interventions occurred from 302 RARP. Among the patients in the RPOT group, eight individuals underwent blood transfusions. However, none of these patients met the hospital-specific criteria for transfusion, which require a hemoglobin level below 70 or symptomatic presentation with a hemoglobin level below 80.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The data suggests routine postoperative laboratory has no bearing on re-admission rates, with patients experiencing significantly shorter hospital stays. Furthermore, our results indicate ineff","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"471-477"},"PeriodicalIF":1.6,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8d/71/rru-15-471.PMC10575481.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41238109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report. Pembrolizumab和Axitinib联合治疗肿瘤栓入下腔静脉的上皮样血管平滑肌脂肪瘤一例报告。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-10-05 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S425887
Chihiro Kawasoe, Yoshi Miyamoto, Kaoru Ito, Takaya Murashima, Takahiro Nagai, Hiroki Takamori, Takumi Kiwaki, Toshio Kamimura, Shoichiro Mukai, Toshiyuki Kamoto

Epithelioid angiomyolipoma (EAML) is a rare variant of AML with malignant potential. It is occasionally difficult to distinguish EAML from renal cell carcinoma (RCC) on imaging. A 72-year-old woman was admitted to our hospital for the treatment of a left renal tumor with relatively high blood flow and a tumor thrombus extending to the inferior vena cava, suggesting RCC. The patient underwent presurgical combination therapy with axitinib and pembrolizumab. This treatment significantly shortened the thrombus, and radical nephrectomy was performed. The pathological findings were compatible with EAML, and the treatment effects were observed. We report a case treated pre-surgically with a combined therapy of pembrolizumab and axitinib, with a favorable response as a treatment option for EAML.

上皮样血管平滑肌脂肪瘤(EAML)是一种罕见的AML变体,具有恶性潜能。在影像学上有时很难区分EAML和肾细胞癌(RCC)。一位72岁的女性因左肾肿瘤入院治疗,该肿瘤血流量相对较高,肿瘤血栓延伸至下腔静脉,提示肾细胞癌。患者在术前接受了阿西替尼和pembrolizumab的联合治疗。这种治疗显著缩短了血栓,并进行了根治性肾切除术。病理结果符合EAML,并观察治疗效果。我们报告了一例术前接受pembrolizumab和阿西替尼联合治疗的病例,作为EAML的治疗选择,疗效良好。
{"title":"Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report.","authors":"Chihiro Kawasoe,&nbsp;Yoshi Miyamoto,&nbsp;Kaoru Ito,&nbsp;Takaya Murashima,&nbsp;Takahiro Nagai,&nbsp;Hiroki Takamori,&nbsp;Takumi Kiwaki,&nbsp;Toshio Kamimura,&nbsp;Shoichiro Mukai,&nbsp;Toshiyuki Kamoto","doi":"10.2147/RRU.S425887","DOIUrl":"https://doi.org/10.2147/RRU.S425887","url":null,"abstract":"<p><p>Epithelioid angiomyolipoma (EAML) is a rare variant of AML with malignant potential. It is occasionally difficult to distinguish EAML from renal cell carcinoma (RCC) on imaging. A 72-year-old woman was admitted to our hospital for the treatment of a left renal tumor with relatively high blood flow and a tumor thrombus extending to the inferior vena cava, suggesting RCC. The patient underwent presurgical combination therapy with axitinib and pembrolizumab. This treatment significantly shortened the thrombus, and radical nephrectomy was performed. The pathological findings were compatible with EAML, and the treatment effects were observed. We report a case treated pre-surgically with a combined therapy of pembrolizumab and axitinib, with a favorable response as a treatment option for EAML.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"447-452"},"PeriodicalIF":1.6,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/2c/rru-15-447.PMC10561617.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Diagnostic Performance of the LINEAR Cromatest and Laboquick URS 10-T Dipsticks Among Urinary Tract Infection Suspects in Addis Ababa, Ethiopia: A Cross-Sectional Study. 埃塞俄比亚亚的斯亚贝巴尿路感染疑似人群中线性Cromatest和Labosquick URS10-T滴剂诊断性能的评估:一项横断面研究。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-10-04 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S434128
Yosef Gebretensaie, Abay Atnafu, Yonas Alemu, Selfu Girma, Kassu Desta

Background: Urinary tract infections (UTIs) bring a significant and serious health-related problem. Repeated infections may lead to the development of renal scarring and end-stage renal dysfunction. Therefore, balancing the choices of UTI diagnostic tools depending on the costs versus accuracy can minimize false results that may subject patients to wrong treatments.

Objective: The objective of the study was to evaluate the diagnostic performance of LINEAR cromatest and Laboquick URS 10-T dipsticks against conventional urine culture at Arsho Advanced Medical Laboratory (AAML), Addis Ababa, Ethiopia.

Methods: A similar cohort of UTI-suspected patients from our previous study, who were prospectively enrolled from Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia, were considered for this analysis. Data analysis was performed using SPSS version 26. The sensitivity, specificity, and predictive value of different dipsticks were calculated using culture as a gold standard. ROC curve analysis was also used to determine diagnostic performance. A test with a P-value of <0.05 was considered statistically significant.

Results: Out of 446 urine samples processed, bacterial growth was observed in 141 (31.6%). Of this figure, 105/141 (74.5%) and 36/141 (25.5%) were from female and male participants, respectively. The sensitivity and specificity of the LINEAR Cromatest dipstick were 83.7% and 67.9%, respectively (P-value <0.001). The Laboquick URS 10-T dipstick showed sensitivity and specificity of 87.9% and 68.5%, respectively (P-value <0.001). The ROC analysis showed an AUC of >0.7 for both dipsticks.

Conclusion: In a setting where there is no access to urine culture, the urine dipstick may be considered an alternative diagnostic tool in the diagnosis of UTIs.

背景:尿路感染(UTIs)带来了一个重大而严重的健康问题。反复感染可能导致肾瘢痕形成和终末期肾功能障碍。因此,根据成本和准确性来平衡UTI诊断工具的选择,可以最大限度地减少可能使患者接受错误治疗的错误结果。目的:本研究旨在评估埃塞俄比亚亚的斯亚贝巴Arsho高级医学实验室(AAML)的线性色氨酸盐和Laboquick URS 10-T滴管对传统尿液培养的诊断性能。方法:我们之前的研究中有一个类似的UTI疑似患者队列,他们前瞻性地从埃塞俄比亚亚的斯亚贝巴的Arsho高级医学实验室招募,被考虑用于本分析。数据分析采用SPSS版本26。以培养物为金标准,计算不同滴管的敏感性、特异性和预测值。ROC曲线分析也用于确定诊断性能。P值为结果的测试:在处理的446个尿液样本中,141个样本(31.6%)观察到细菌生长。在这一数字中,105/141个样本(74.5%)和36/141个(25.5%)分别来自女性和男性参与者。LINERAL Cromatest试纸的敏感性和特异性分别为83.7%和67.9%(两种试纸的P值P值均为0.7)。结论:在无法进行尿液培养的情况下,尿液试纸可被视为诊断尿路感染的替代诊断工具。
{"title":"Evaluation of the Diagnostic Performance of the LINEAR Cromatest and Laboquick URS 10-T Dipsticks Among Urinary Tract Infection Suspects in Addis Ababa, Ethiopia: A Cross-Sectional Study.","authors":"Yosef Gebretensaie,&nbsp;Abay Atnafu,&nbsp;Yonas Alemu,&nbsp;Selfu Girma,&nbsp;Kassu Desta","doi":"10.2147/RRU.S434128","DOIUrl":"10.2147/RRU.S434128","url":null,"abstract":"<p><strong>Background: </strong>Urinary tract infections (UTIs) bring a significant and serious health-related problem. Repeated infections may lead to the development of renal scarring and end-stage renal dysfunction. Therefore, balancing the choices of UTI diagnostic tools depending on the costs versus accuracy can minimize false results that may subject patients to wrong treatments.</p><p><strong>Objective: </strong>The objective of the study was to evaluate the diagnostic performance of LINEAR cromatest and Laboquick URS 10-T dipsticks against conventional urine culture at Arsho Advanced Medical Laboratory (AAML), Addis Ababa, Ethiopia.</p><p><strong>Methods: </strong>A similar cohort of UTI-suspected patients from our previous study, who were prospectively enrolled from Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia, were considered for this analysis. Data analysis was performed using SPSS version 26. The sensitivity, specificity, and predictive value of different dipsticks were calculated using culture as a gold standard. ROC curve analysis was also used to determine diagnostic performance. A test with a P-value of <0.05 was considered statistically significant.</p><p><strong>Results: </strong>Out of 446 urine samples processed, bacterial growth was observed in 141 (31.6%). Of this figure, 105/141 (74.5%) and 36/141 (25.5%) were from female and male participants, respectively. The sensitivity and specificity of the LINEAR Cromatest dipstick were 83.7% and 67.9%, respectively (<i>P</i>-value <0.001). The Laboquick URS 10-T dipstick showed sensitivity and specificity of 87.9% and 68.5%, respectively (<i>P</i>-value <0.001). The ROC analysis showed an AUC of >0.7 for both dipsticks.</p><p><strong>Conclusion: </strong>In a setting where there is no access to urine culture, the urine dipstick may be considered an alternative diagnostic tool in the diagnosis of UTIs.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"437-445"},"PeriodicalIF":1.6,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/ce/rru-15-437.PMC10560765.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience in Retrocaval Ureter at Saint Paul's Hospital Millennium Medical College: A Case Series. 圣保罗医院千禧医学院治疗腔静脉后输尿管的经验:病例系列。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-09-22 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S419718
Adugna Getachew Mideksa, Tolesa Yadeta Huluka, Masresha Solomon Dino, Mensur Mohammed Ahmed

Retrocaval ureter is a rare congenital vascular anomaly described as the passage of the ureter behind the inferior vena cava (IVC) and then turning around the IVC to attain the final lateral position. The condition is usually associated with obstruction in the ipsilateral kidney, causing different degrees of hydronephrosis and complications associated with urinary stasis, such as stone formation. Imaging has a crucial role in the diagnosis and management of retrocaval ureter. CT urography may be the procedure of choice to confirm the diagnosis and avoid retrograde ureteropyelography. Indications for treatment include flank pain, recurrent infection, hydronephrosis, and stone formation due to obstruction. Surgical management is standard and can be done through either an open, laparoscopic, or robotic approach. In this case series, we are going to see two cases of retrocaval ureter in a 56-year-old male and a 14-year-old male child who presented with a right flank of less than a couple of months duration. The first case has an associated horseshoe kidney and a solitary secondary stone. Both cases were surgically managed with open ureteral division, relocation, and ureteroureterostomy. Both have uneventful post-operative follow-ups.

下腔静脉后输尿管是一种罕见的先天性血管异常,被描述为输尿管在下腔静脉(IVC)后通过,然后绕过下腔静脉到达最终的侧向位置。这种情况通常与同侧肾脏阻塞有关,导致不同程度的肾积水和与尿瘀相关的并发症,如结石形成。影像学在腔静脉后输尿管的诊断和治疗中起着至关重要的作用。CT尿路造影可能是确认诊断和避免逆行输尿管肾盂造影的首选方法。治疗适应症包括腰痛、复发性感染、肾积水和梗阻性结石形成。手术管理是标准的,可以通过开放式、腹腔镜或机器人方法进行。在这个病例系列中,我们将看到两例腔静脉后输尿管病例,一名56岁的男性和一名14岁的男性儿童,他们的右翼持续时间不到几个月。第一个病例有一个相关的马蹄形肾和一个孤立的继发性结石。两例均采用开放式输尿管切开、移位和输尿管造口术进行手术治疗。两人的术后随访都很顺利。
{"title":"Experience in Retrocaval Ureter at Saint Paul's Hospital Millennium Medical College: A Case Series.","authors":"Adugna Getachew Mideksa,&nbsp;Tolesa Yadeta Huluka,&nbsp;Masresha Solomon Dino,&nbsp;Mensur Mohammed Ahmed","doi":"10.2147/RRU.S419718","DOIUrl":"https://doi.org/10.2147/RRU.S419718","url":null,"abstract":"<p><p>Retrocaval ureter is a rare congenital vascular anomaly described as the passage of the ureter behind the inferior vena cava (IVC) and then turning around the IVC to attain the final lateral position. The condition is usually associated with obstruction in the ipsilateral kidney, causing different degrees of hydronephrosis and complications associated with urinary stasis, such as stone formation. Imaging has a crucial role in the diagnosis and management of retrocaval ureter. CT urography may be the procedure of choice to confirm the diagnosis and avoid retrograde ureteropyelography. Indications for treatment include flank pain, recurrent infection, hydronephrosis, and stone formation due to obstruction. Surgical management is standard and can be done through either an open, laparoscopic, or robotic approach. In this case series, we are going to see two cases of retrocaval ureter in a 56-year-old male and a 14-year-old male child who presented with a right flank of less than a couple of months duration. The first case has an associated horseshoe kidney and a solitary secondary stone. Both cases were surgically managed with open ureteral division, relocation, and ureteroureterostomy. Both have uneventful post-operative follow-ups.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"431-436"},"PeriodicalIF":1.6,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/29/1a/rru-15-431.PMC10522493.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41150130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complaints of Men with Uncorrected Distal Hypospadias. 男性尿道下裂未矫正的投诉。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-09-21 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S405901
Nicol Corbin Bush, Warren Snodgrass

Purpose: The few available reports regarding adults living with distal hypospadias give disparate views of the functional and aesthetic impact of this penile birth defect when it is not corrected. We reviewed symptoms and findings in consecutive men with unrepaired distal hypospadias and report those observations.

Material and methods: Men with uncorrected hypospadias were queried regarding urinary symptoms, sexual dysfunction, and aesthetic concerns. Glans fusion around the meatus was measured. Penile curvature was confirmed by photographs of erections, and its degree objectively measured in those undergoing surgery.

Results: There were 51 men with a mean age of 42 years (18-63). None had glans fusion around the meatus, and the main symptom was urine spraying in 81%. Penile curvature was present in 33%. Painful sexual activity was reported by 34% due to penile curvature, exposed urethral mucosa, or a scrotal web. All but one man experienced functional problems. In addition, 60% were bothered by their abnormal appearance.

Conclusion: All but one of these men with uncorrected distal hypospadias had penile dysfunction, and 60% were additionally concerned about the atypical appearance of their penis. These results offer a different perspective than earlier reports which said that most men with uncorrected distal hypospadias were not bothered by their condition, and many were not aware of it.

目的:为数不多的关于患有远端尿道下裂的成年人的报告对这种阴茎出生缺陷在未纠正的情况下对功能和美学的影响给出了不同的看法。我们回顾了连续男性尿道下裂未修复的症状和发现,并报告了这些观察结果。材料和方法:询问未矫正尿道下裂的男性的泌尿系统症状、性功能障碍和审美问题。测量了肉肉周围的腺体融合。勃起的照片证实了阴茎弯曲,并在接受手术的人身上客观地测量了其程度。结果:男性51例,平均年龄42岁(18-63岁)。尿道口周围无龟头融合,主要症状为尿潴留者占81%。阴茎弯曲占33%。据报道,34%的性活动疼痛是由于阴茎弯曲、尿道粘膜暴露或阴囊网引起的。除一人外,其他人都出现了功能问题。此外,60%的人对自己的异常外表感到困扰。结论:除1例未矫正的尿道下裂患者外,其余均存在阴茎功能障碍,60%的患者还担心其阴茎外观不典型。这些结果提供了一个与早期报告不同的视角,早期报告称,大多数未经矫正的远端尿道下裂男性对自己的状况并不感到困扰,许多人也没有意识到这一点。
{"title":"Complaints of Men with Uncorrected Distal Hypospadias.","authors":"Nicol Corbin Bush,&nbsp;Warren Snodgrass","doi":"10.2147/RRU.S405901","DOIUrl":"10.2147/RRU.S405901","url":null,"abstract":"<p><strong>Purpose: </strong>The few available reports regarding adults living with distal hypospadias give disparate views of the functional and aesthetic impact of this penile birth defect when it is not corrected. We reviewed symptoms and findings in consecutive men with unrepaired distal hypospadias and report those observations.</p><p><strong>Material and methods: </strong>Men with uncorrected hypospadias were queried regarding urinary symptoms, sexual dysfunction, and aesthetic concerns. Glans fusion around the meatus was measured. Penile curvature was confirmed by photographs of erections, and its degree objectively measured in those undergoing surgery.</p><p><strong>Results: </strong>There were 51 men with a mean age of 42 years (18-63). None had glans fusion around the meatus, and the main symptom was urine spraying in 81%. Penile curvature was present in 33%. Painful sexual activity was reported by 34% due to penile curvature, exposed urethral mucosa, or a scrotal web. All but one man experienced functional problems. In addition, 60% were bothered by their abnormal appearance.</p><p><strong>Conclusion: </strong>All but one of these men with uncorrected distal hypospadias had penile dysfunction, and 60% were additionally concerned about the atypical appearance of their penis. These results offer a different perspective than earlier reports which said that most men with uncorrected distal hypospadias were not bothered by their condition, and many were not aware of it.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"425-430"},"PeriodicalIF":1.6,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/6f/rru-15-425.PMC10519173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41176994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traumatic Kidney Injury: A 6-Year Retrospective Study in Childhood and Adolescence. 外伤性肾损伤:儿童和青少年6年回顾性研究。
IF 1.6 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-09-20 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S424273
Muhammad Asykar Palinrungi, Muhammad Faruk, Robert Christeven

Background: Traumatic kidney injuries are the most common urinary tract injuries. Pediatric patients are more susceptible to renal injury from blunt trauma than adults because of anatomic factors. The aim of this publication was to provide a reference for traumatic kidney injury in the pediatric group based on the study in our center.

Methods: A retrospective study was conducted from January 2014 to December 2019 to review medical records of children admitted with renal trauma. Relevant findings including demographics, mechanisms and grades of injury, clinical parameters, interventions, and outcomes were recorded.

Results: Thirty-three pediatric patients were investigated. Males experienced traumatic kidney injury more often than the females with a ratio of 10:1. Most cases occurred during the adolescent (12-18) years (81.82%). Left-side kidney injury (63.64%) was more frequent than right side (36.36%). Most cases (96.97%) were caused by blunt trauma, mainly traffic accidents (81.82%). Most patients (90.91%) had stable hemodynamics. Grade IV kidney injury was the most frequently found injury (39.39%). The cause of renal function disturbance was based on the blood urea nitrogen/creatinine (BUN/Cr) ratio with 21.87% of patients suffering from intra-renal causes and 12.5% from pre-renal causes. No significant association between different grades and BUN/creatinine ratio was found. Isolated renal injuries were found in 54.54% of patients. Most patients were treated conservatively (87.88%), and survival was 96.97%.

Conclusion: Non-operative management is safe and yields good outcomes in kidney trauma patients with stable hemodynamics. Renal trauma severity is not associated with the BUN/Cr ratio.

背景:外伤性肾损伤是最常见的尿路损伤。由于解剖因素,儿童患者比成人更容易受到钝性创伤引起的肾损伤。本出版物的目的是根据我们中心的研究,为儿科创伤性肾损伤提供参考。方法:对2014年1月至2019年12月收治的肾损伤儿童的医疗记录进行回顾性研究。记录相关发现,包括人口统计学、损伤机制和分级、临床参数、干预措施和结果。结果:对33例儿科患者进行了调查。男性经历创伤性肾损伤的频率高于女性,比例为10:1。大多数病例发生在青少年(12-18)岁(81.82%)。左侧肾损伤(63.64%)比右侧肾损伤(36.36%)更常见。大多数病例(96.97%)是由钝性创伤引起的,主要是交通事故(81.82%)。大多数患者(90.91%)血流动力学稳定。IV级肾损伤是最常见的损伤(39.39%)。肾功能紊乱的原因是基于血尿素氮/肌酐(BUN/Cr)比率,21.87%的患者患有肾内原因,12.5%的患者患有肾脏前原因。未发现不同级别与BUN/肌酸酐比率之间存在显著相关性。54.54%的患者出现孤立性肾损伤。结论:对于血流动力学稳定的肾损伤患者,非手术治疗是安全的,效果良好。肾损伤的严重程度与BUN/Cr比率无关。
{"title":"Traumatic Kidney Injury: A 6-Year Retrospective Study in Childhood and Adolescence.","authors":"Muhammad Asykar Palinrungi,&nbsp;Muhammad Faruk,&nbsp;Robert Christeven","doi":"10.2147/RRU.S424273","DOIUrl":"https://doi.org/10.2147/RRU.S424273","url":null,"abstract":"<p><strong>Background: </strong>Traumatic kidney injuries are the most common urinary tract injuries. Pediatric patients are more susceptible to renal injury from blunt trauma than adults because of anatomic factors. The aim of this publication was to provide a reference for traumatic kidney injury in the pediatric group based on the study in our center.</p><p><strong>Methods: </strong>A retrospective study was conducted from January 2014 to December 2019 to review medical records of children admitted with renal trauma. Relevant findings including demographics, mechanisms and grades of injury, clinical parameters, interventions, and outcomes were recorded.</p><p><strong>Results: </strong>Thirty-three pediatric patients were investigated. Males experienced traumatic kidney injury more often than the females with a ratio of 10:1. Most cases occurred during the adolescent (12-18) years (81.82%). Left-side kidney injury (63.64%) was more frequent than right side (36.36%). Most cases (96.97%) were caused by blunt trauma, mainly traffic accidents (81.82%). Most patients (90.91%) had stable hemodynamics. Grade IV kidney injury was the most frequently found injury (39.39%). The cause of renal function disturbance was based on the blood urea nitrogen/creatinine (BUN/Cr) ratio with 21.87% of patients suffering from intra-renal causes and 12.5% from pre-renal causes. No significant association between different grades and BUN/creatinine ratio was found. Isolated renal injuries were found in 54.54% of patients. Most patients were treated conservatively (87.88%), and survival was 96.97%.</p><p><strong>Conclusion: </strong>Non-operative management is safe and yields good outcomes in kidney trauma patients with stable hemodynamics. Renal trauma severity is not associated with the BUN/Cr ratio.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"415-424"},"PeriodicalIF":1.6,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/44/96/rru-15-415.PMC10518142.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41152519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncommon Haemorrhagic Cystitis of Infectious Origin: A Narrative Review for Urologists. 源于感染的罕见出血性膀胱炎:供泌尿科医生参考的叙述性综述。
IF 2 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-08-04 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S412278
Francesca Ambrosini, Niccolò Riccardi, Sara Occhineri, Tommaso Matucci, Irene Paraboschi, Alessandro Calarco, Alfredo Berrettini, Giusy Tiseo, Diana Canetti, André Van Der Merwe, Carlo Terrone, Guglielmo Mantica

Purpose: Haemorrhagic cystitis may be due to different etiologies with infectious diseases representing an insidious cause to diagnose. The aim of this narrative review is to provide a comprehensive overview of less common but difficult-to-diagnose causes of infectious haemorrhagic cystitis of bacterial, mycobacterial, and parasitic origin, Moreover, we highlight possible diagnostic tools and currently available treatment options in order to give an updated tool for urologists to use in daily practice.

Patients and methods: The search engine PubMed was used to select peer-reviewed articles published from 1/Jan/2010 to 31/Aug/2022.

Results: Bacteria, fungal, TB and schistosomiasis are uncommon causes of haemorrhagic cystitis burdened by high morbidity, especially if not promptly diagnosed.

Conclusion: Because haemorrhagic cystitis ranges in severity from mild dysuria associated with pelvic discomfort to severe life-threatening haemorrhage, punctual diagnosis, and immediate treatment are essential to avoid further complications.

目的:出血性膀胱炎可能由不同病因引起,其中感染性疾病是一种隐匿的诊断病因。本综述旨在全面概述细菌性、分枝杆菌性和寄生虫性感染性出血性膀胱炎中不常见但难以诊断的病因,此外,我们还强调了可能的诊断工具和目前可用的治疗方案,以便为泌尿科医生在日常工作中提供最新的工具:使用PubMed搜索引擎选择2010年1月1日至2022年8月31日发表的同行评审文章:结果:细菌、真菌、结核病和血吸虫病是导致出血性膀胱炎的不常见原因,尤其是在未得到及时诊断的情况下,发病率较高:结论:由于出血性膀胱炎的严重程度不等,从伴有盆腔不适的轻度排尿困难到危及生命的严重大出血,因此及时诊断和立即治疗对避免进一步的并发症至关重要。
{"title":"Uncommon Haemorrhagic Cystitis of Infectious Origin: A Narrative Review for Urologists.","authors":"Francesca Ambrosini, Niccolò Riccardi, Sara Occhineri, Tommaso Matucci, Irene Paraboschi, Alessandro Calarco, Alfredo Berrettini, Giusy Tiseo, Diana Canetti, André Van Der Merwe, Carlo Terrone, Guglielmo Mantica","doi":"10.2147/RRU.S412278","DOIUrl":"10.2147/RRU.S412278","url":null,"abstract":"<p><strong>Purpose: </strong>Haemorrhagic cystitis may be due to different etiologies with infectious diseases representing an insidious cause to diagnose. The aim of this narrative review is to provide a comprehensive overview of less common but difficult-to-diagnose causes of infectious haemorrhagic cystitis of bacterial, mycobacterial, and parasitic origin, Moreover, we highlight possible diagnostic tools and currently available treatment options in order to give an updated tool for urologists to use in daily practice.</p><p><strong>Patients and methods: </strong>The search engine PubMed was used to select peer-reviewed articles published from 1/Jan/2010 to 31/Aug/2022.</p><p><strong>Results: </strong>Bacteria, fungal, TB and schistosomiasis are uncommon causes of haemorrhagic cystitis burdened by high morbidity, especially if not promptly diagnosed.</p><p><strong>Conclusion: </strong>Because haemorrhagic cystitis ranges in severity from mild dysuria associated with pelvic discomfort to severe life-threatening haemorrhage, punctual diagnosis, and immediate treatment are essential to avoid further complications.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"365-373"},"PeriodicalIF":2.0,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/37/rru-15-365.PMC10411501.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes. 肌浸润性膀胱癌的系统治疗决策算法:临床复杂性和改善疗效的导航。
IF 2 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-07-07 eCollection Date: 2023-01-01 DOI: 10.2147/RRU.S386549
Megan Giles, Simon J Crabb

Muscle-invasive bladder cancer has poor prognosis. If organ confined, it is potentially curable; however, across all prognostic groups, approximately half of patients will relapse. For patients with advanced disease, the median overall survival remains under two years. Systemic treatment options are centered on the use of platinum-based combination chemotherapy, with the choice of cisplatin- or carboplatin-based regimens determined on the basis of criteria including performance status and renal function. PD-1/PD-L1 checkpoint-directed immunotherapy has been established for use in advanced disease with modest overall improvements in survival outcomes. Based on current data, optimal utilization appears to be a switch maintenance strategy on completion of chemotherapy. In the curative setting, cisplatin-based chemotherapy provides modest improvements in cure rates in those fit to receive it. Data on the use of adjuvant immunotherapy are currently contradictory, with disease-free survival demonstrated for adjuvant nivolumab, but not atezolizumab, and no overall survival benefit has yet been confirmed. The Nectin-4 directed antibody drug conjugate enfortumab vedotin is an established treatment option for patients previously treated with both chemotherapy and immunotherapy. The emerging therapeutic targets under evaluation include Trop-2 with sacituzumab govitecan, fibroblast growth factor receptors, HER2, and DNA repair deficiency in biomarker-selected patients. The development of properly validated predictive biomarkers has proven challenging for this disease and should be a central priority in the future development of treatment options. This review summarizes the available systemic treatment options in both palliative and curative disease settings, and highlights the available evidence and current limitations for making treatment recommendations.

肌肉浸润性膀胱癌预后较差。如果器官局限,则有可能治愈;但在所有预后组别中,约有一半的患者会复发。对于晚期患者,中位总生存期仍不足两年。全身治疗方案以使用铂类联合化疗为中心,顺铂或卡铂方案的选择取决于患者的表现状态和肾功能等标准。PD-1/PD-L1检查点导向免疫疗法已被确定用于晚期疾病的治疗,其总体生存结果略有改善。根据目前的数据,最佳的使用方法似乎是在完成化疗后转换维持策略。在治愈性治疗中,顺铂化疗可适度提高适合接受该疗法的患者的治愈率。目前,辅助免疫疗法的使用数据相互矛盾,尼妥珠单抗(nivolumab)的辅助治疗可获得无病生存期,而阿特珠单抗(atezolizumab)则无法获得无病生存期,总体生存期获益尚未得到证实。对于既往接受过化疗和免疫疗法的患者来说,Nectin-4 引导的抗体药物共轭物 enfortumab vedotin 是一种成熟的治疗选择。目前正在评估的新兴治疗靶点包括:Trop-2 与 sacituzumab govitecan、成纤维细胞生长因子受体、HER2 以及生物标志物选定患者的 DNA 修复缺陷。事实证明,开发经过适当验证的预测性生物标志物对该疾病具有挑战性,因此应成为未来开发治疗方案的核心优先事项。本综述总结了姑息性和治疗性疾病的现有系统性治疗方案,并强调了现有证据和目前在提出治疗建议方面的局限性。
{"title":"Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes.","authors":"Megan Giles, Simon J Crabb","doi":"10.2147/RRU.S386549","DOIUrl":"10.2147/RRU.S386549","url":null,"abstract":"<p><p>Muscle-invasive bladder cancer has poor prognosis. If organ confined, it is potentially curable; however, across all prognostic groups, approximately half of patients will relapse. For patients with advanced disease, the median overall survival remains under two years. Systemic treatment options are centered on the use of platinum-based combination chemotherapy, with the choice of cisplatin- or carboplatin-based regimens determined on the basis of criteria including performance status and renal function. PD-1/PD-L1 checkpoint-directed immunotherapy has been established for use in advanced disease with modest overall improvements in survival outcomes. Based on current data, optimal utilization appears to be a switch maintenance strategy on completion of chemotherapy. In the curative setting, cisplatin-based chemotherapy provides modest improvements in cure rates in those fit to receive it. Data on the use of adjuvant immunotherapy are currently contradictory, with disease-free survival demonstrated for adjuvant nivolumab, but not atezolizumab, and no overall survival benefit has yet been confirmed. The Nectin-4 directed antibody drug conjugate enfortumab vedotin is an established treatment option for patients previously treated with both chemotherapy and immunotherapy. The emerging therapeutic targets under evaluation include Trop-2 with sacituzumab govitecan, fibroblast growth factor receptors, HER2, and DNA repair deficiency in biomarker-selected patients. The development of properly validated predictive biomarkers has proven challenging for this disease and should be a central priority in the future development of treatment options. This review summarizes the available systemic treatment options in both palliative and curative disease settings, and highlights the available evidence and current limitations for making treatment recommendations.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"15 ","pages":"321-331"},"PeriodicalIF":2.0,"publicationDate":"2023-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/39/rru-15-321.PMC10335269.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9817981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research and Reports in Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1